1. Home
  2. SIBN vs NBTX Comparison

SIBN vs NBTX Comparison

Compare SIBN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$17.48

Market Cap

886.9M

Sector

Health Care

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$21.38

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
NBTX
Founded
2008
2003
Country
United States
France
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
886.9M
1.0B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
SIBN
NBTX
Price
$17.48
$21.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$25.57
$8.00
AVG Volume (30 Days)
533.2K
37.8K
Earning Date
02-23-2026
09-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,578,000.00
$11,930,711.00
Revenue This Year
$21.44
N/A
Revenue Next Year
$15.37
$145.24
P/E Ratio
N/A
N/A
Revenue Growth
23.27
N/A
52 Week Low
$12.50
$2.85
52 Week High
$21.89
$30.35

Technical Indicators

Market Signals
Indicator
SIBN
NBTX
Relative Strength Index (RSI) 35.31 49.97
Support Level $17.01 $19.61
Resistance Level $21.89 $21.68
Average True Range (ATR) 0.91 1.06
MACD -0.39 -0.15
Stochastic Oscillator 8.82 44.44

Price Performance

Historical Comparison
SIBN
NBTX

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: